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Microbiological tests on cerebrospinal fluid (CSF) utilize a common urgent-care procedure that does not take into account
the chemical and cytological characteristics of the CSF, resulting sometimes in an unnecessary use of human and diagnos-
tic resources. The aim of this study was to retrospectively validate a simple scoring system (bacterial meningitis-Careggi
score [BM-CASCO]) based on blood and CSF sample chemical/cytological parameters for evaluating the probability of
acute bacterial meningitis (ABM) in adults. BM-CASCO (range, 0 to 6) was defined by the following parameters: CSF cell
count, CSF protein levels, CSF lactate levels, CSF glucose-to-serum glucose ratio, and peripheral neutrophil count. BM-
CASCO was retrospectively calculated for 784 cases of suspected ABM in adult subjects observed during a four-and-a-half-
year-period (2010 to 2014) at the emergency department (ED) of a large tertiary-care teaching hospital in Italy. Among the
28 confirmed ABM cases (3.5%), Streptococcus pneumoniae was the most frequent cause (16 cases). All ABM cases showed a
BM-CASCO value of>3. Most negative cases (591/756) exhibited a BM-CASCO value of<1, which was adopted in our
laboratory as a cutoff to not proceed with urgent microbiological analysis of CSF in cases of suspected ABM in adults.
During a subsequent 1-year follow-up, the introduction of the BM-CASCO in the diagnostic workflow of ABM in adults
resulted in a significant decrease in unnecessary microbiological analysis, with no false negatives. In conclusion, BM-
CASCO appears to be an accurate and simple scoring system for optimization of the microbiological diagnostic workflow
of ABM in adults.
Cases of acute bacterial meningitis (ABM) require prompt di-agnosis and treatment due to significantmortality rates (1, 2).
A delay in starting appropriate therapy may worsen the prognosis
(1). Recently, the epidemiology of ABM has shifted to older age
groups due to the increasing child vaccination rates against the
most common meningeal pathogens (3, 4). Streptococcus pneu-
moniae is currently the leading cause of ABM in adults and is
associated with a 17 to 30% mortality rate (2–4).
Diagnosis of ABM at the time of clinical presentation is often
difficult and requires laboratory investigation of cerebrospinal
fluid (CSF) specimens. A Gram stain of the CSF sediment is a
widely used test for the rapid detection of bacteria but may suffer
from low sensitivity (5). When evaluated on adult subjects not
previously treated with antibiotics, the CSF Gram stain has been
reported to have a sensitivity between 60% and 92% (6). Sensitiv-
ity can be increased by molecular tests, such as real-time PCR
(RT-PCR), but these tests are still not widespread due to their high
cost and the need for expensive equipment and experienced lab-
oratory personnel. Bacterial culture remains the gold standard for
microbiological diagnosis of ABM, but it requires longer times
and suffers from reduced sensitivity in cases involving previous
antimicrobial chemotherapy (6). In addition, biochemical and cy-
tological alterations of CSF may help in the diagnostic process of
ABM. Themost common alterations include polymorphonuclear
leukocytosis, decreased glucose concentration, and increased pro-
tein and lactate concentrations (5, 6).
Lumbar puncture (LP) for CSF examination represents a com-
mon procedure performed in emergency departments (EDs)
whendealingwith subjectswith suspectedABM(7). In the current
diagnostic workflow, the microbiological analysis of CSF samples
(Gram stain, culture and, possibly, RT-PCR for commonbacterial
pathogens) is usually carried out as an urgent procedure with all
CSF samples, regardless of the biochemical and cytological pa-
rameters of CSF.
In this study, we evaluated the performance of a simple scoring
system (bacterial meningitis-Careggi score [BM-CASCO]), based
on biochemical and cytological CSF and blood parameters, that
could be used for triage of suspected cases of ABM in adults to be
subjected to urgent microbiological workup of CSF, eliminating
useless tests and sparing human resources.
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MATERIALS AND METHODS
Data sources and study period. The hospital discharge register andmed-
ical records of all patients evaluated in the ED between 1 January 2010 and
31 May 2014, and who were considered suspected cases of ABM, were
examined for clinical, laboratory, and microbiological data for the retro-
spective evaluation of BM-CASCO.
Definitions. A suspected case of adult ABM was defined as any case,
age18 years, admitted to the ED and subjected to LP for CSF analysis to
confirm a diagnosis of ABM. A confirmed case of ABM was defined as a
clinically compatible case with a positive CSF culture and/or RT-PCR test
for a bacterial pathogen in a subject age 18 years. A contaminant was
defined as a bacterial isolate from CSF in a case that was not compatible
with a diagnosis of ABM according to the clinical presentation and other
laboratory data.
Data collection and analysis.We retrospectively collected the follow-
ing data from clinical and laboratory records: date of birth, gender, results
of CSF Gram stain, results of CSF bacteriological cultures, results of CSF
molecular analysis, peripheral blood and CSF leukocyte (WBC) count,
CSF glucose-to-serum glucose ratio, CSF protein concentration, CSF lac-
tate concentration, and diagnosis at discharge. Molecular analysis of CSF
for bacterial pathogens was carried out only in selected cases, when the
results of Gram stain were considered not informative, at the discretion of
the clinical microbiologist in charge of the case. The data were entered
into an Excel data sheet and analyzed with IBM SPSS Statistics (Armonk,
NY,USA). An evaluation of sensitivity, specificity, and negative predictive
value of the BM-CASCO was carried out as described previously (8).
Ethical approval was not needed because the study used fully anonymized
observational data that were obtained as part of an assessment of routine
clinical service.
Design of the score. The score was designed based on clinical experi-
ence and a reviewof the literature (5–7, 9). BM-CASCO(range, 0 to 6)was
defined as the sum of a score attributed to the following parameters: 2
points for a CSF leukocyte count of 50 cells/l and 1 point for a CSF
protein concentration of80 mg/dl, a CSF lactate concentration of35
mg/dl, a CSF glucose-to-serum glucose ratio of 45%, or a peripheral
neutrophil leukocyte count of10,000 cells/l (Table 1).
Evaluation of the implementationphase. In the period of 1 June 2014
to 31May 2015, the BM-CASCOwas applied in our laboratory diagnostic
workflow for adult patients admitted to the EDwith a suspected diagnosis
of ABM. Following this new procedure, microbiological analysis of CSF
was no longer performed when the BM-CASCO was 1, unless specifi-
cally requested by the ED physician, who was left with the option to over-
ride the procedure based on clinical judgment.
RESULTS
Between 1 January 2010 and 31May 2014, a total of 813 suspected
cases (397 female and 416 male) of ABM age 18 years were
evaluated at the EDofCareggiUniversityHospital, Florence, Italy.
During the same period, the ED evaluated about 150 patients/day.
Twenty-nine cases were excluded from subsequent analysis due to
incomplete clinical data. All of them had a negative CSF culture.
Among the 784 cases included in the analysis, 55 (7.0%) had a
CSF-positive result for bacteria (54 yielded positive cultures, and
one was positive by RT-PCR test only). Of these positives, 27 were
interpreted to be contaminations, considering the clinical and lab-
oratory findings. In those cases, the most common bacterial spe-
cies were coagulase-negative staphylococci (Table 2). The overall
rate of contaminated CSF was 3.4%. The remaining 28 cases with
a CSF-positive result for bacteria were confirmed cases of ABM
according to clinical and laboratory findings. In one case, only the
molecular test was positive, likely because of previous antimicro-
bial treatment. The most common pathogen was S. pneumoniae
(Table 2). These 28ABMcaseswere considered to be true positives
for an evaluation of the BM-CASCO.
All cases of confirmed ABM showed a BM-CASCO value of
TABLE 1 Values of blood and CSF parameters used to calculate the
BM-CASCOa
Blood/CSF parameters Cutoff value BM-CASCO score
CSF cell count 50 cells/l 0
50 cells/l 2
CSF protein concn 80 mg/dl 0
80 mg/dl 1
CSF lactate concn 35 mg/dl 0
35 mg/dl 1
CSF glucose-to-serum glucose ratio 45% 0
45% 1
Peripheral neutrophil count 10,000 cells/l 0
10,000 cells/l 1
a The score results from the sum of all individual values and can range between 0 and 6.
TABLE 2 Distribution of the BM-CASCO among 784 cases of suspect ABM evaluated at the ED of Careggi University Hospital from 1 January 2010
to 31 May 2014
Definitive diagnosis CSF culture result
No. (%) with BM-CASCO value:
Total (no. [%])0 1 2 3 4 5 6
No ABM Negative 384 185 75 44 32 4 5 729 (93.0)
Contaminateda 19 3 1 1 3 0 0 27 (3.45)
Confirmed ABM Positiveb 0 0 0 2 1 5 19 27 (3.45)
Negativec 0 0 0 0 0 0 1 1 (0.1)
Total 403 (51.4) 188 (24.0) 76 (9.7) 47 (6.0) 36 (4.6) 9 (1.1) 25 (3.2) 784 (100)
a Bacterial species cultured in these cases included Staphylococcus epidermidis (n 5), Staphylococcus warneri (n 4), Staphylococcus hominis (n 4), Staphylococcus capitis (n 3),
Staphylococcus auricularis (n 1), Staphylococcus cohnii (n 1), Staphylococcus haemolyticus (n 1), Streptococcus mitis (n 1), Streptococcus spp. (alpha-hemolytic) (n 1),
Micrococcus luteus (n 2), Corynebacterium minutissimum (n 1), Bacillus spp. (n 1), Acinetobacter lwoffii (n 1), and Escherichia coli (n 1). In all these cases, the bacterial
isolates were considered to be contaminants based on clinical and laboratory findings. The E. coli strain, in particular, was grown from the CSF specimen from a 60-year-old woman
with a history of chronic migraine, who was discharged the day after admission with a diagnosis of chronic migraine and was not given any antimicrobial treatment.
b Bacterial species cultured in these cases included S. pneumoniae (n 15), Staphylococcus aureus (n 4), Neisseria meningitidis (n 4), Streptococcus agalactiae (n 1),
Haemophilus influenzae (n 1), and Listeria monocytogenes (n 2).
c This case was positive for S. pneumoniae with the RT-PCR test.
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3, withmedian andmean values of 6 and 5.2, respectively (Table
2). Considering all evaluable samples, 591/784 (75.4%) yielded a
BM-CASCO value of1 (Table 2).
When applying a BM-CASCO value of 1 as a cutoff to ex-
clude the diagnosis of ABM, the sensitivity and negative predictive
value (NPV) were 100% (95% confidence interval [CI], 87.6% to
100%) and 100% (95% CI, 99% to 100%), respectively, while
specificity was 78.1% (95% CI, 75% to 81.7%).
Based on these results, the BM-CASCO was introduced in the
diagnostic workflow of ABM in adults admitted to the ED of our
hospital. Altogether, during the period of 1 June 2014 to 31 May
2015, a total of 215 CSF specimens were obtained from adults
admitted to the ED with diagnosis of suspected ABM. Of these,
152 (70%) yielded a BM-CASCO value of 1 and were not sub-
jected to further microbiological analysis. None of these cases
were eventually diagnosed as ABM cases according to the subse-
quent clinical follow-up. Among the 63 cases with a BM-CASCO
value of1 who were subjected to further microbiological analy-
sis, five (7.2%) were eventually confirmed to be ABM cases. Con-
sidering the subset of 120 CSF specimens received during on-call
shifts of the clinical microbiology service, 96 of them (80%) ex-
hibited a BM-CASCO value of1 and did not require activation
of the on-call procedure.
DISCUSSION
Although the number of definite indications for LP has decreased
with the introduction of streamlined neuroimaging procedures,
LP is commonly performed in EDs in adult subjects with some
combination of fever, altered mental status, headache, or menin-
geal signs to confirmdiagnosis of ABM, andCSF sample analysis is
usually performed in accordance with urgent procedures, includ-
ing cell counts, biochemistry, and microbiological evaluation (7,
10, 11). Our clinical microbiology laboratory was used to perform
CSF Gram stain and bacterial culture (and also RT-PCR in se-
lected cases) as urgent exams, on a 24-hours-a-day, 7-days-a-week
schedule, on all CSF specimens collected in the ED from cases of
suspected ABM.
A retrospective review of the laboratory reports of our hospital,
however, showed that 75% of CSF microbiological analyses were
performed on samples with no or minimal changes in white cell
counts and biochemical parameters, and that only 3.5%of cases of
suspected ABM observed in the ED were eventually confirmed.
These findings prompted us to elaborate a CSF processing strategy
to limit urgent and inappropriate microbiological tests while
maintaining an optimal performance for diagnosing ABM. The
strategy was based on a simple score, the BM-CASCO, calculated
froma set of five parameters derived from the initial clinical chem-
istryworkup thatwere chosen by a reviewof the literature (5–7, 9).
Although previous scoring systems have been proposed to distin-
guish bacterial from viral meningitis (12–16), to the best of our
knowledge, this is the first scoring system based only on clinical
chemistry data for triage of suspected cases of ABM in adults to be
subjected to further microbiological analysis of CSF. As a matter
of fact, differently from other scores (14–16), neither microbio-
logical (e.g., CSF Gram stain) nor clinical rules were taken into
account. Gram stain, which is usually present in some previously
reported score systems, has been substituted by an easily replicable
laboratory parameter, such as measurement of CSF lactate levels.
This parameter was shown in a recent meta-analysis to discrimi-
nate well between bacterial and aseptic meningitis (9).
Considering the objective, the BM-CASCO prediction rules
were designed to exhibit maximal sensitivity to avoid the misclas-
FIG 1 Diagnostic laboratory workflow for ABM in adults.
New Score System for ABM in Adults
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sification of even a single ABM case. Although all CSF analyses for
suspected ABM cases from a four-and-a-half-year period were
included, the main limitation of our study is represented by the
retrospective design. Taking into account this limitation, we ap-
plied a conservative cutoff of1 for the BM-CASCO, even though
all cases of confirmed ABM showed a score of3.
In virtue of the 100% NPV with a BM-CASCO value of1, a
new diagnostic procedure for CSFworkup has been applied in our
laboratory, in agreement with recommendations of EDphysicians
and infectious diseases specialists, since 1 June 2014. In accor-
dance with this new procedure, microbiological analysis of CSF is
performed only when the BM-CASCO value is1. The ED phy-
sicians, however, are aware that ABM cases with no abnormalities
in the initial CSF testing are possible, although extremely rare,
with specific clinical conditions (e.g., congenital or acquired im-
mune deficiencies in host defense mechanisms, strong epidemio-
logical context, neurosurgery, prior antibiotic therapy, etc.) (17–
20); they are allowed to override the new procedure and request
further urgent microbiological analysis of CSF, irrespective of the
BM-CASCO (Fig. 1).
In fact, after a 1-year follow-up since the introduction of the
new procedure based on BM-CASCO, we were able to document
an 80% reduction in urgent microbiological test performed on
CSF specimens referred by the ED in cases of suspected ABM in
adults, with a significant sparing of human resources either during
working hours or during the on-call shifts.
In an era of financial constraints, budget planning is manda-
tory, and costs related to unnecessary tests and emergency calls of
highly skilled staff should be optimized. Carrying out CSF analysis
as an urgent procedure regardless of the biochemical and cytolog-
ical parameters generates a useless waste of human and material
resources and, in cases of contaminated samples, might even pro-
vide misleading results. With this perspective, BM-CASCO could
represent a valid tool for an appropriate laboratory procedure for
CSF analysis in case of adult patients with suspected ABM, elimi-
nating useless tests and correctly allocating human resources.
However, considering that bacterial meningitis with no abnor-
malities in initial CSF testing is possible, although extremely rare,
repeat CSF analysis should be considered, and antimicrobial ther-
apy must be started immediately in the presence of any signs of
sepsis or meningitis (7, 18–20).
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